Atlas Trials

A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Clinical trial NCT02361086 · COMPLETED

Trial details

NCT number
NCT02361086
Sponsor
Innocrin Pharmaceutical
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Castration-resistant Prostate CancerCRPC
Start date
2014-06-01
Primary completion
2017-12-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.